$1.30
0.021.56%
In chiusura: -
$1.33
0.032.31%
After hour: Sep 30, 4:13 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su AN2 Therapeutics Inc (NASDAQ:ANTX) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 30.46K a 58.76K. Questo rappresenta il 0.37% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in AN2 Therapeutics Corp (XNAS:ANTX) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 113.06K azioni scambiate al giorno, ci vorrebbero 1 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
58.76K
Vendite allo scoperto %
0.37%
Giorni di copertura
1
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ANTX | AN2 Therapeutics, Inc. Common | 09/15/2025 | 09/24/2025 | 0.37% | 16,016,738 | 58,758 | 113,061 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 08/29/2025 | 09/10/2025 | 0.19% | 16,016,738 | 30,463 | 104,637 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 08/15/2025 | 08/26/2025 | 0.10% | 16,016,738 | 15,217 | 60,336 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 07/31/2025 | 08/11/2025 | 0.08% | 18,866,293 | 14,430 | 79,066 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 07/15/2025 | 07/24/2025 | 0.18% | 18,866,293 | 33,212 | 69,719 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 06/30/2025 | 07/10/2025 | 0.18% | 18,866,293 | 34,475 | 446,949 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 06/13/2025 | 06/25/2025 | 0.28% | 18,866,293 | 52,543 | 159,422 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 05/30/2025 | 06/10/2025 | 0.18% | 18,866,293 | 33,176 | 377,595 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 05/15/2025 | 05/27/2025 | 0.22% | 18,866,293 | 42,423 | 233,212 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 04/30/2025 | 05/09/2025 | 0.18% | 19,505,504 | 36,054 | 32,367 | 1.11 | |
ANTX | AN2 Therapeutics, Inc. Common | 04/15/2025 | 04/25/2025 | 0.42% | 19,505,504 | 82,335 | 70,887 | 1.16 | |
ANTX | AN2 Therapeutics, Inc. Common | 03/31/2025 | 04/09/2025 | 0.31% | 19,505,504 | 61,160 | 80,512 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 03/14/2025 | 03/25/2025 | 0.37% | 19,285,674 | 71,203 | 159,678 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 02/28/2025 | 03/11/2025 | 0.58% | 19,285,674 | 112,040 | 157,667 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 02/14/2025 | 02/26/2025 | 0.41% | 19,285,674 | 78,578 | 156,231 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 01/31/2025 | 02/11/2025 | 0.31% | 19,285,674 | 58,838 | 115,411 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 01/15/2025 | 01/27/2025 | 0.41% | 19,285,674 | 78,586 | 125,357 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 12/31/2024 | 01/10/2025 | 0.47% | 19,285,674 | 90,026 | 184,833 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 12/13/2024 | 12/24/2024 | 0.38% | 19,285,674 | 74,084 | 285,614 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 11/29/2024 | 12/10/2024 | 0.37% | 19,285,674 | 71,424 | 1,774,853 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 11/15/2024 | 11/26/2024 | 1.97% | 19,285,674 | 379,597 | 566,814 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 10/31/2024 | 11/11/2024 | 0.69% | 19,249,215 | 133,574 | 216,444 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 10/15/2024 | 10/24/2024 | 0.72% | 19,249,215 | 139,119 | 101,884 | 1.37 | |
ANTX | AN2 Therapeutics, Inc. Common | 09/30/2024 | 10/09/2024 | 0.98% | 19,249,215 | 188,480 | 220,915 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 09/13/2024 | 09/24/2024 | 1.30% | 19,249,215 | 249,628 | 282,866 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 08/30/2024 | 09/11/2024 | 0.76% | 19,249,215 | 146,885 | 885,933 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 08/15/2024 | 08/26/2024 | 2.01% | 19,249,215 | 386,842 | 1,737,193 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 07/31/2024 | 08/09/2024 | 3.55% | 19,235,824 | 683,402 | 188,636 | 3.62 | |
ANTX | AN2 Therapeutics, Inc. Common | 07/15/2024 | 07/24/2024 | 3.59% | 19,235,824 | 690,674 | 203,391 | 3.4 | |
ANTX | AN2 Therapeutics, Inc. Common | 06/28/2024 | 07/10/2024 | 3.52% | 19,235,824 | 676,962 | 90,446 | 7.48 | |
ANTX | AN2 Therapeutics, Inc. Common | 06/14/2024 | 06/26/2024 | 3.68% | 19,235,824 | 707,266 | 79,678 | 8.88 | |
ANTX | AN2 Therapeutics, Inc. Common | 05/31/2024 | 06/11/2024 | 3.88% | 19,235,824 | 746,870 | 236,533 | 3.16 | |
ANTX | AN2 Therapeutics, Inc. Common | 05/15/2024 | 05/24/2024 | 3.61% | 19,235,824 | 693,840 | 104,803 | 6.62 | |
ANTX | AN2 Therapeutics, Inc. Common | 04/30/2024 | 05/09/2024 | 3.83% | 19,235,824 | 736,895 | 99,952 | 7.37 | |
ANTX | AN2 Therapeutics, Inc. Common | 04/15/2024 | 04/24/2024 | 2.39% | 19,235,824 | 460,513 | 482,798 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 03/28/2024 | 04/09/2024 | 1.32% | 20,644,536 | 272,509 | 361,327 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 03/15/2024 | 03/26/2024 | 1.55% | 20,615,606 | 319,420 | 403,978 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 02/29/2024 | 03/11/2024 | 1.43% | 20,615,606 | 295,295 | 628,906 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 02/15/2024 | 02/27/2024 | 1.63% | 20,615,606 | 336,249 | 896,768 | 1 | |
ANTX | AN2 Therapeutics, Inc. Common | 01/31/2024 | 02/09/2024 | 1.36% | 20,615,606 | 280,320 | 103,908 | 2.7 | |
ANTX | AN2 Therapeutics, Inc. Common | 01/12/2024 | 01/24/2024 | 1.47% | 20,615,606 | 302,100 | 91,259 | 3.31 | |
ANTX | AN2 Therapeutics, Inc. Common | 12/29/2023 | 01/10/2024 | 1.43% | 20,615,606 | 294,389 | 96,859 | 3.04 | |
ANTX | AN2 Therapeutics, Inc. Common | 12/15/2023 | 12/27/2023 | 0.81% | 20,615,606 | 166,643 | 148,678 | 1.12 | |
ANTX | AN2 Therapeutics, Inc. Common | 11/30/2023 | 12/11/2023 | 1.37% | 20,615,606 | 282,097 | 65,700 | 4.29 | |
ANTX | AN2 Therapeutics, Inc. Common | 11/15/2023 | 11/27/2023 | 1.55% | 20,615,606 | 319,018 | 38,207 | 8.35 | |
ANTX | AN2 Therapeutics, Inc. Common | 10/31/2023 | 11/09/2023 | 1.24% | 20,580,391 | 255,770 | 26,863 | 9.52 | |
ANTX | AN2 Therapeutics, Inc. Common | 10/13/2023 | 10/24/2023 | 1.11% | 20,580,391 | 227,447 | 41,597 | 5.47 | |
ANTX | AN2 Therapeutics, Inc. Common | 09/29/2023 | 10/10/2023 | 0.64% | 20,580,391 | 131,462 | 128,188 | 1.03 |
In cerca di azioni più vendute allo scoperto?